Norway turns salmon cells into a new test bed for disease resistance

By
Stonehaven Analytics
/
Oct 21, 2026

Researchers are using cultured salmon cells, CRISPR screening and gill models to identify disease-resistance traits, potentially reducing live-fish challenge tests and giving breeders faster, more ethical tools as warming waters increase aquaculture risks.

Norwegian researchers are using cultured salmon cells and gene-editing tools to cut reliance on live-fish challenge tests, a shift that could change how disease resistance is studied across aquaculture. The work matters because outbreaks still erode farm performance, pressure welfare standards and complicate breeding decisions as producers contend with warmer, more volatile waters. If validated, these methods could give breeders faster and more ethical ways to identify resistant stocks, while leaving live-animal trials for questions that still require a whole-fish response.

At Campus Ås, the Norwegian University of Life Sciences, the Norwegian Veterinary Institute and Nofima are testing whether laboratory systems can substitute for some of the work long done in infected fish. The PETRI-FISH project uses CRISPR-based screening in Atlantic salmon cells to look for genes linked to resistance to infectious salmon anaemia virus, while CELLCRISP is probing traits ranging from growth and wound healing to fat deposition and fillet quality.

The Norwegian Veterinary Institute is also refining cell lines such as ASG-10, a gill model used to study toxins, microplastics, water quality and pathogens. Researchers say such models can screen large numbers of variants more efficiently, but they still need careful validation before they can stand in for living fish.

"This news service is powered by an AI tool that curates and enhances the content related to animal health. The articles provided are for informational purposes only and should not be considered professional or veterinary advice. The content presented does not reflect the views or opinions of Stonehaven Analytics."

Scroll to Top